OMID Holdings, Inc.

OMID Holdings, Inc.

OMID
OMID Holdings, Inc.US flagOther OTC
0.02
USD
+0.01
- -
1.64MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

CEO
Adam Frank
Full Time Employees
6
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
1130 Springtown Road, Suite B Phillipsburg NJ United States of America 8865
IPO Date
Mar 21, 2013
Business
OMID Holdings, Inc. OMID Holdings, Inc. is a health and wellness company that develops, manufactures, and sells hemp-based and CBD-infused consumer products, including tinctures, lotions, vaporizers, and beverage enhancers; the company operates a FDA-registered, Food Grade Certified manufacturing facility in Alpha, New Jersey, and serves private label and in-house brands with high-purity cannabis extracts verified by third-party lab testing. Founded in 1998 and headquartered in Phillipsburg, New Jersey, OMID Holdings, Inc. focuses on the U.S. market while expanding into non-CBD product lines such as skincare formulations and nootropic-enhanced offerings targeting athletic and biohacking segments. In recent developments, the company acquired the Champ Life health and wellness brand in 2021 via a share-for-share transaction with no net change to its issued shares, introducing a 5% royalty on Champ Life net revenues and plans for adaptogen ingredients from herbs and mushrooms; OMID has also broadened its scope beyond hemp to include conventional wellness products, enhancing its portfolio diversification.

Company News

  • Cannabis Wellness Co. OMID Holdings Reports Record Revenue For Q4 & FY 2021